Less than 5% of cases correspond to early-onset AD, a familial form of the disease caused by genetic alterations, including mutations in genes encoding the amyloid-β precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2; Karch and Goate, 2015). Here, PSEN1 is linked to Alzheimer disease.